课题基金 / 基金详情

210 POLONIUM RADIATION AND DITHIOLS

210 POLONIUM RADIATION AND DITHIOLS
210 钋辐射和二硫醇
批准号:
3193310
负责人:
H VASKEN APOSHIAN
金额:
$9.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-07-08 至 1991-06-30

项目摘要

项目成果

H VASKEN APOSHIAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
210Polonium is a radioactive daughter of radon. It is an alpha emitter and thus hazardous if allowed to enter the body. For man, inhalation and ingestion are the major portals of entry. There have been "disasters" caused by accidents with 210Po, e.g. the Windscale accident in England. One of the occupational dangers of uranium miners is 210Po inhalation. There has been recent concern about radon and 210Po concentrations in the interior air of poorly ventilated buildings and homes resulting from materials used in site preparation and/or construction materials. In addition, accidents in nuclear facilities have occurred with 210Po. The results of a small preliminary experiment in this laboratory indicate that the administration of either DMSA or DMPA, water soluble and less toxic analogs of BAL, protects rats from a subacute lethal dose of 210Po. Our aims are to confirm and expand the results of the initial preliminary experiment, to determine whether BAL analogs redistribute 210Po from radiation sensitive tissue (e.g. spleen) to radiation insensitive tissues (e.g. muscle), to determine if these dithiols increase 210Po excretion and to determine whether BAL and its less toxic analogs differ in life-saving activity in rats given a lethal dose of 210Polonium. These studies can help evaluate the damage done to a living body by the presence of alpha emitters in mining environments, in some poorly ventilated work places and houses, in nuclear facilities and other environments. In addition, it can make experimental information available to physicians who have to treat humans after exposure to alpha emitters.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Tissue decorporation of polonium-210 in rats by DMPA.
DMPA 对大鼠体内钋 210 的组织修饰。
DOI: --
发表时间: 1987
期刊: Research communications in chemical pathology and pharmacology
影响因子: --
作者: [Aposhian,HV, Dart,RC, Aposhian,MM, Dawson,BV]
通讯作者: Dawson,BV
N-(2,3-dimercaptopropyl)phthalamidic acid (DMPA) increases polonium-210 excretion.
N-(2,3-二巯基丙基)邻苯二甲酰胺酸 (DMPA) 可增加钋 210 的排泄。
DOI: 10.1007/bf01140585
发表时间: 1990
期刊: Biology of metals
影响因子: --
作者: [Bogdan,GM, Aposhian,HV]
通讯作者: Aposhian,HV
DOI: 10.1016/0272-0590(90)90264-k
发表时间: 1990
期刊: Fundamental and applied toxicology : official journal of the Society of Toxicology
影响因子: --
作者: [Zheng,W, Maiorino,RM, Brendel,K, Aposhian,HV]
通讯作者: Aposhian,HV
DOI: 10.1016/0006-2952(89)90261-x
发表时间: 1989
期刊: Biochemical pharmacology
影响因子: 5.8
作者: [Maiorino,RM, Aposhian,HV]
通讯作者: Aposhian,HV
7
    The Human Genetics of Arsenic Biotra
    • 批准号:
      6901470
    • 项目类别:
    • 资助金额:
      $38.89万
    • 财政年份:
      2005
    • 负责人:
      H VASKEN APOSHIAN
    • 依托单位:
    Biological fate of arsenic species
    • 批准号:
      6577205
    • 项目类别:
    • 资助金额:
      $14.22万
    • 财政年份:
      2002
    • 负责人:
      H VASKEN APOSHIAN
    • 依托单位:
    Biological fate of arsenic species
    • 批准号:
      6590734
    • 项目类别:
    • 资助金额:
      $14.22万
    • 财政年份:
      2002
    • 负责人:
      H VASKEN APOSHIAN
    • 依托单位:
    Biological fate of arsenic species
    • 批准号:
      6666396
    • 项目类别:
    • 资助金额:
      $14.22万
    • 财政年份:
      2002
    • 负责人:
      H VASKEN APOSHIAN
    • 依托单位:
    海外基金